MedTrace Logo

The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical Trial

NCT01943136 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2013-12-19

No results posted yet for this study

Summary

This study will be an investigator-blinded, patient-blinded, assessor-blinded, parallel-group, randomized clinical trial. It aims to evaluate the efficacy of one-week twice-daily application of topical papaya leaf extract ointment compared to mupirocin ointment in achieving clinical cure among patients with impetigo.

Conditions

  • Impetigo

Interventions

DRUG

papaya 1% extract ointment

DRUG

mupirocin 2% ointment

Sponsors & Collaborators

  • St. Luke's Medical Center

    collaborator OTHER

  • Philippine Dermatological Society

    lead NETWORK

Principal Investigators

  • Mia Angela C Verzosa, MD · St. Luke's Medical Center

  • Pearl Weena Marie E Sabido, MD · St. Luke's Medical Center

  • Janine L. Quijano, MD · St. Luke's Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2015-06-30

Countries

  • Philippines

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01943136 on ClinicalTrials.gov